For the latest ecancer COVID-19 resources, click on this link

Videos [604]
News [1816]
Articles [67]
Editorials [3]
Conferences [38]
elearning [15]
COVID-19 and cancer: Useful resources
COVID-19 and cancer: Useful resources
New vulnerability found in lung squamous cancer may facilitate drug targeting
New vulnerability found in lung squamous cancer may facilitate drug targeting
ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer
ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer
ESMO 2020: No benefit for post-operative radiotherapy in non-small-cell lung cancer
ESMO 2020: No benefit for post-operative radiotherapy in non-small-cell lung cancer
ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
New model predicts oesophageal cancer eight years early for half of all patients
New model predicts oesophageal cancer eight years early for half of all patients
FDA approves pralsetinib for lung cancer with RET gene fusions
FDA approves pralsetinib for lung cancer with RET gene fusions
'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' face disproportionate risk of death from lung disease and lung cancer
Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma
Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma
Cancer's ongoing evolution
Cancer's ongoing evolution

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation